Brazil

BMI Core View: Offshoring manufacturing to low-cost bases will accelerate. Multinational drugmakers are looking to cut costs during the patent cliff and production is being shifted... 2012-01-18

BMI View: Multinational drugmakers are increasingly seeking expansion in Latin America to reduce their dependence on the slow-growing markets in Europe and the US. The region's two... 2012-01-17

BMI View: Emerging markets will drive medical device industry growth. The importance of emerging markets to large multinational medical equipment producers cannot be overstated and... 2012-01-10

BMI View: Multinational drug companies and medical device makers can benefit from the Brazilian government's promotion of the local industry by collaborating with local companies to... 2012-01-04

BMI View: Despite strong underlying fundamentals, Brazil's pharmaceutical market growth rate is expected to slow due to concerns over the country's long-term fiscal policy and, to a... 2011-12-21

BMI View: Leading medical device companies, particularly those based in Europe, will increasingly embrace opportunities in emerging markets. However, they will have to monitor economic... 2011-12-12

BMI View: While we are encouraged by a string of recent research and development (R&D) investments in Brazil, it is worth noting the impact of an increasingly government-led healthcare... 2011-12-06